LISA SHOEMAKER: Open Payments
NPI 1922621762 · BIG RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$609 in 34 payments from 13 companies in 2025. Trend: 2023 $425 · 2024 $1,037 · 2025 $609
Food & beverage: $609
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $171 |
| Novo Nordisk Inc | 5 | $94 |
| PFIZER INC. | 4 | $75 |
| Lilly USA, LLC | 2 | $43 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| Alkermes, Inc. | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| SPR Therapeutics, Inc | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $21 |
Products named: UBRELVY, ELIQUIS, VRAYLAR, MOUNJARO, NURTEC ODT, VIVITROL, Saxenda, QULIPTA.
Industry payments across MI — which companies pay providers there.
